Chemotherapy-Induced Peripheral Neuropathic Pain in Cancer Patients/Survivors

Authors

  • Andreia Capela Serviço de Oncologia Médica. Centro Hospitalar Vila Nova de Gaia/Espinho. Vila Nova de Gaia; Associação de Investigação de Cuidados de Suporte em Oncologia. Vila Nova de Gaia.
  • Rosário Alonso Colégio da Competência em Medicina da Dor. Ordem dos Médicos. Lisboa.
  • António Araújo Serviço de Oncologia Médica. Centro Hospitalar Universitário do Porto. Porto; Instituto de Ciências Biomédicas Abel Salazar. Porto.
  • Beatriz Craveiro-Lopes Centro Multidisciplinar da Dor. Hospital Garcia de Orta. Almada.
  • Rosa Maria Fragoso Serviço de Oncologia Médica e Unidade de Estudo e Tratamento de Dor. Instituto Português de Oncologia do Porto Francisco Gentil. Porto.
  • Hélder Mansinho Serviço de Hemato-Oncologia Clínica. Hospital Garcia de Orta. Almada.
  • Rita Moutinho Serviço de Anestesiologia e Unidade Multidisciplinar de Dor. Centro Hospitalar Vila Nova de Gaia/Espinho. Vila Nova de Gaia.
  • José Alberto Teixeira Serviço de Oncologia Médica. Hospital Beatriz Ângelo. Loures.
  • Cláudia Vieira Serviço de Oncologia Médica. Instituto Português de Oncologia do Porto Francisco Gentil. Porto; Sociedade Portuguesa de Oncologia. Coimbra.
  • Dalila Veiga Serviço de Anestesiologia. Unidade Multidisciplinar de Dor Crónica. Centro Hospitalar Universitário do Porto. Porto; Instituto de Ciências Biomédicas Abel Salazar. Porto.

DOI:

https://doi.org/10.20344/amp.18750

Keywords:

Antineoplastic Agents/adverse effects, Cancer Survivors, Neuralgia/etiology, Peripheral Nervous System Diseases/chemically induced

Abstract

N/a.

Downloads

Download data is not yet available.

References

Direção-Geral da Saúde. Norma 043/2011 (Atualização de 13/07/2017): Tratamento farmacológico da dor neuropática no adulto e idoso. [consultado 2021 abr 15]. Disponível em: https://nocs.pt/dorneuropatica-adulto-e-idoso/.

Edwards HL, Mulvey MR, Bennett MI. Cancer-related neuropathic pain. Cancers. 2019;11:373. DOI: https://doi.org/10.3390/cancers11030373

Kerckhove N, Collin A, Condé S, Chaleteix C, Pezet D, Balayssac D. Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review. Front Pharmacol. 2017;8:86. DOI: https://doi.org/10.3389/fphar.2017.00086

Zajączkowska R, Kocot-Kępska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. Mechanisms of chemotherapy-induced peripheral neuropathy. Int J Mol Sci. 2019;20:1451. DOI: https://doi.org/10.3390/ijms20061451

Quintão NL, Santin JR, Stoeberl LC, Corrêa TP, Melato J, Costa R. Pharmacological treatment of chemotherapy-induced neuropathic pain: PPARγ agonists as a promising tool. Front Neurosci. 2019;13:907. DOI: https://doi.org/10.3389/fnins.2019.00907

Burgess J, Ferdousi M, Gosal D, Boon C, Matsumoto K, Marshall A, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021;9:385-450. DOI: https://doi.org/10.1007/s40487-021-00168-y

Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-inducedperipheral neuropathy: a current review. Ann Neurol. 2017;81:772-81. DOI: https://doi.org/10.1002/ana.24951

Guimarães J, Silveira F. Abordagem diagnóstica das neuropatias periféricas. Acta Med Port. 2008;21:83-8.

Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS, Jahn P, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31:1306-19. DOI: https://doi.org/10.1016/j.annonc.2020.07.003

Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO Guideline Update. J Clin Oncol. 2020;38: 3325-48. DOI: https://doi.org/10.1200/JCO.20.01399

Downloads

Published

2023-02-01

How to Cite

1.
Capela A, Alonso R, Araújo A, Craveiro-Lopes B, Fragoso RM, Mansinho H, Moutinho R, Teixeira JA, Vieira C, Veiga D. Chemotherapy-Induced Peripheral Neuropathic Pain in Cancer Patients/Survivors. Acta Med Port [Internet]. 2023 Feb. 1 [cited 2024 Nov. 14];36(2):77-80. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/18750

Issue

Vol. 36 No. 2 (2023): February

Section

Perspective

License

Copyright (c) 2023 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC